121/344US=395 / Tese/FAP
Fanni VSS. Expressão imunoistoquímica do receptor de FSH em tecido testicular tumoral, peritumoral, normal e de pacientes inférteis. [Immunohistochemical expression of FSH receptor in tumoral, peritumoral, normal and infertile patients testicular tissue]. São Paulo, 2012. 76 p. Dissertação(Mestrado)-Fundação Antônio Prudente.

Disponível em: http://accamargo.phlnet.com.br/MESTRADO/2012/Victor/Victor.pdf

Curriculum Lattes

IMUNOISTOQUIMICA; NEOPLASIA TESTICULAR; SINDROME DA DISGENESIA TESTICULAR; INFERTILIDADE; HORMONIO FOLICULO ESTIMULANTE

122/344US=85 / Biol/Mol
Kim SH, Kim SH, Song YC, Song YS. Effect of epidermal growth factor receptor inhibitor alone and in combination with cisplatin on growth of vulvar cancer cells. In: Diederich M. Natural compounds and their role in apoptotic cell signaling pathways. Boston: Blackwell, 2009. p. 642-8. (Annals of the New York Academy of Sciences Vol 1171) ISBN 978-1-57331-737-5.

EGFR; AG1478; CISPLATINA; VULVAR CANCER

123/344US=96 / Biol/Mol
Zhy YS, Imperato-McGinley JL. 5&*945;-Reductase isozymes and androgenic actions in the prostate. In: Bradlow KL, Carruba G. Steroid enzymes and cancer. Boston: Blackwell, 2009. p. 43-56. (Annals of the New York Academy of Science,v.155) ISBN 9978-1-57331-745-0.

5&*945;-REDUTASE ISOZIMAS E ACCOES ANDROGENICOS NA PROSTATA; 5&*945;-REDUTASE; 5&*945;RD; RECEPTOR DE ANDROGENO; AR; RECEPTOR DE ESTROGENO; ER; HIPERPLASIA BENIGNA DA PROSTATA; BPH; CANCER DE PROSTATA; ANTIGENO PROSTATICO ESPECIFICO; PSA; EXPRESSAO DO GENE

124/344US=96 / Biol/Mol
Bulun SE, Lin Z, Zhao H, Lu M, Amin S, Reierstad S, Chen D. Regulation of aromatase expression in breast cancer tissue. In: Bradlow KL, Carruba G. Steroid enzymes and cancer. Boston: Blackwell, 2009. p. 121-31. (Annals of the New York Academy of Science,v.155) ISBN 9978-1-57331-745-0.

BRCA-1; ARF; CREB; AROMATASE; CANCER DE MAMA; PROSTAGLANDINA E2; JUNHO QUINASE; P38 QUINASE; RECEPTOR DE ESTROGENIO-&*945;; INIBIDOR DA AROMATASE

125/344US=96 / Biol/Mol
Santen R, Cavalieri E, Rogan E, Russo J, Guttenplan J, Ingle J, Yue W. Estrogen mediation of breast tumor formation involves estrogen receptor-dependent, as well as independent, genotoxic effects. In: Bradlow KL, Carruba G. Steroid enzymes and cancer. Boston: Blackwell, 2009. p. 132-40. (Annals of the New York Academy of Science,v.155) ISBN 9978-1-57331-745-0.

ESTROGENIO; 4-OH-ESTRADIOL; CANCER DE MAMA; GENOTOXICIDADE; EFEITOS

126/344US=96 / Biol/Mol
Dunn BK, Ryan A. Phase 3 trials of aromatase inhibitors for breast cancer prevention. In: Bradlow KL, Carruba G. Steroid enzymes and cancer. Boston: Blackwell, 2009. p. 141-61. (Annals of the New York Academy of Science,v.155) ISBN 9978-1-57331-745-0.

PREVENCAO DO CANCER DE MAMA; INIBIDOR DA AROMATASE; MODULADOR SELETIVO DO RECEPTOR DE ESTROGENIO; TAMOXIFENO; CANCER DE MAMA CONTRALATERAL; ARIMIDEX; TAMOXIFENO SOZINHO OU EM COMBINACAO; SERM; TAM; AI; CLBC; ATAC

127/344US=96 / Biol/Mol
Carruba G. Aromatase in nontumoral and malignant human liver tissues and cells. In: Bradlow KL, Carruba G. Steroid enzymes and cancer. Boston: Blackwell, 2009. p. 187-93. (Annals of the New York Academy of Science,v.155) ISBN 9978-1-57331-745-0.

AREG; HCC; ER; AROMATASE; ESTROGENIO; FIGADO; METABOLISMO; AMPHIREGULIN; CARCINOMA HEPATOCELULAR; RECEPTOR DE ESTROGENO

128/344US=96 / Biol/Mol
Márquez-Garbán DC, Chen HW, Goodglick L, Fishbein MC, Pietras RJ. Targeting aromatase and estrogen signaling in human non-small cell lung cancer. In: Bradlow KL, Carruba G. Steroid enzymes and cancer. Boston: Blackwell, 2009. p. 194-205. (Annals of the New York Academy of Science,v.155) ISBN 9978-1-57331-745-0.

NSCLC; CYP19; EGFR; NAO-PEQUENAS CELULAS DE PULMAO; AROMATASE; RECEPTOR DE ESTROGENO; RECEPTOR DO FATOR DE CRESCIMENTO EPIDERMICO; RECEPTOR DO FATOR DE CRESCIMENTO ENDOTELIAL VASCULAR; ANASTRAZOLE; EXEMESTANO; FULVESTRANT; VANDETANIB

129/344US=96 / Biol/Mol
Berasain C, Castillo J, Perugorria MJ, Latasa MU, Pietro J, Avila MA. Inflammation and liver cancer. In: Bradlow KL, Carruba G. Steroid enzymes and cancer. Boston: Blackwell, 2009. p. 206-21. (Annals of the New York Academy of Science,v.155) ISBN 9978-1-57331-745-0.

CARCINOMA HEPATOCELULAR; INFLAMACAO; FATOR NUCLEAR-&*1181;B; NF-&*1181;B; STAT3; IL-6; RECEPTOR DO FATOR DE CRESCIMENTO EPIDERMICO; AMPHIREGULIN; TOLL-LIKE RECEPTOR; TLR; RECONHECIMENTO DE RECEPTORES PADRAO; PRRS

130/344US=96 / Biol/Mol
Amodio R, Zarcone M, Agostara B, Staiti R, Granata OM, Carruba G, Traina A. Endocrine therapy in metastatic breast cancer: data from breast cancer registry of Palermo, 1999-2005. In: Bradlow KL, Carruba G. Steroid enzymes and cancer. Boston: Blackwell, 2009. p. 227-31. (Annals of the New York Academy of Science,v.155) ISBN 9978-1-57331-745-0.

CANCER DE MAMA METASTATICO; ANALISE CIRURGICA; SOBREVIDA GLOBAL; OS; TRATAMENTO HORMONAL; RECEPTOR POSITIVO; RECEPTOR NEGATIVO

131/344US=96 / Biol/Mol
Campisi I, Granata OM, Cocciadiferro L, Calabrò M, Polito LM, Carruba G. 16¦Á-hydroxyestrone inhibits estrogen sulfotransferase activity in human liver cancer cells. In: Bradlow KL, Carruba G. Steroid enzymes and cancer. Boston: Blackwell, 2009. p. 237-42. (Annals of the New York Academy of Science,v.155) ISBN 9978-1-57331-745-0.

ESTROG¨ºNIO SULFOTRANSFERASE; MODULADORES SELETIVOS DE RECEPTOR DE ESTROG¨ºNIO; SERMS; 16¦A-OHE1; C¨¦LULAS HEPG2

132/344US=96 / Biol/Mol
Miceli V, Cervello M, Azzolina A, Montalto G, Calabrò M, Carruba G. Aromatase and amphiregulin are correspondingly expressed in human liver cancer cells. In: Bradlow KL, Carruba G. Steroid enzymes and cancer. Boston: Blackwell, 2009. p. 252-6. (Annals of the New York Academy of Science,v.155) ISBN 9978-1-57331-745-0.

ARO; AREG; HCC; ER; AROMATASE; AMPHIREGULIN; CARCINOMA HEPATOCELULAR HUMANO; RECEPTOR DE ESTROGENO

133/344US=96 / Biol/Mol
Pandini G, Genua M, Frasca F, Vigneri R, Belfiore A. Sex steroids upregulate the IGF-1R in prostate cancer cells through a nongenotropic pathaway. In: Bradlow KL, Carruba G. Steroid enzymes and cancer. Boston: Blackwell, 2009. p. 263-7. (Annals of the New York Academy of Science,v.155) ISBN 9978-1-57331-745-0.

CANCER DE PROSTATA; ESTROGENIO ANDROGENO FATOR DE CRESCIMENTO SEMELHANTE A INSULINA; IGF-1 RECEPTOR

134/344US=101 / Câncer
Ritzenthaler JD, Roman J, ShouWei H. PPARß/&*948; agonist increases the expression of PGE2 receptor subtype EP4 in human lung carcinoma cells. In: Kozlov SV, editor. Inflammation and cancer: methods and protocols. volume 2, molecular analysis and pathways. New York: Humana Press, 2009. p. 309-23. (Methods in Molecular Biology, 512) ISBN 978-1-60327-529-3.

PPARß/&*948;; EP4; NSCLC; EMSA; TRANSFECCAO

135/344US=45-B / Cab/Pesc
Smith BD, Haffty BG. Prognostic factors in patients with head and neck cancer. In: Harrison LB, Sessions RB, Hong WK. Head and neck cancer: a multidisciplinary approach. 3rd ed. Philadelphia: J B Lippincott, 2009. p. 51-75. ISBN 978-0-7817-7136-8.

CANCER DE CABECA E PESCOCO; FATORES PROGNOSTICOS; NEOPLASIA PRIMARIA; LINFONODOS CERVICAIS; FATORES DEMOGRAFICOS; COMORBIDADE; ESTADO NUTRICIONAL; ANEMIA; FATORES PROGNOSTICOS MOLECULARES; P53; MARCADORES RELACIONADOS A ANGIOGENESE; CICLINA D1; RECEPTOR DO FACTOR DE CRESCIMENTO EPIDERMICO (EGFR)

136/344US=49-G / Câncer
Hanna JA, Bordeaux J, Rimm DL, Agarwal S. The function, proteolytic processing, and histopathology of met in cancer. In: Woude GFV, Klein G. Advances in cancer research. Amsterdam: Elsevier, 2009. p. 1-23. ISBN 978-0-12-3747730.

PROCESSAMENTO PROTEOLITICO; HISTOPATOLOGIA DE MET EM CANCER; PROPRIEDADES ONCOGENICAS DO MET; CRUZADA RECEPTOR; PROCESSAMENTO PROTEOLITICO DE MET; LOCALIZACAO NECLEAR DE MET; HISTOLOGIA E EXPRESSAO DE MET EM CANCER

137/344US=9-A / Ginecologia
Dorigo O, Mertínez-Maza O, Berek JS. Biologic, targeted, and immune therapies. In: Berek JS, Hacker NF. Berek and Hacker's gynecologic oncology. 5th ed. Philadelphia: Lippincott Williams & Wilkins, 2009. p. 41-56. ISBN 978-0-7817-9512-8.

ONCOLOGIA GINECOLOGICA; TERAPIAS BIOLOGICA; IMUNOTERAPIA; ANGIOGENESE; FATOR DE CRESCIMENTO ENDOTELIAL VASCULAR; INIBIDORES DO RECEPTOR DO FATOR DE CRESCIMENTO EPIDERMICO; RECEPTOR DO FATOR DE CRESCIMENTO EPIDERMICO; HER-2/NEU; COMPONENTES DO SISTEMA IMUNOLOGICO

138/344US=31 / Fisioterapia
Forte V, Arakaki JSO, Rosa LS. Transplante de pulmão. In: Sarmento GJV. Fisioterapia hospitalar pré e pós-operatórios. Barueri: Manole, 2009. p. 3-12. ISBN 85-2042565-7.

TRANSPLANTE PULMONAR; TRANSPLANTE DE PULMAO. INDICACOES; DOENCA PULMONAR OBSTRUTIVA CRONICA; DEFICIENCIA DE ALFA1 ANTITRIPSINA; FIBROSE CISTICA; BRONQUIECTASIAS; FIBROSE PULMONAR IDIOPATICA; FIBROSE PULMONAR SECUNDARIA; HIPERTENSAO PULMONAR; TRANSPLANTE DE PULMAO. TIPOS; SELECAO DO RECEPTOR; SELECAO DO DOADOR; CUIDADOS POS-OPERATORIO; MONITORIZACAO HEMODINAMICA; VENTILACAO MECANICA; ANASTOMOSE; INFECCAO; ANTIBIOTICOTERAPIA; IMUNOSSUPRESSAO

139/344US=103 / Câncer
Zografos GC, Michalopoulos NV, Zagouri F. Hormone therapies. In: Missailidis S. Anticancer therapeutics. New Jersey: Wiley Blackwell, 2008. p. 159-86. ISBN 978-0-470-72303-6.

TERAPIA HORMONAL; TERAPIA ALVO; RECEPTOR DE ESTROGENIO; TERAPIA GUIADA POR PROGESTERONA; TUMORES NEUROENDOCRINOS

140/344US=105 / Câncer
Speiser DE, Krieg AM. Stimulation of toll-like receptor 9 for enhacing vaccination. In: Orentas R, Hodge JW, Johnson BD. Cancer vaccines and tumor immunity. New Jersey: Wiley-Interscience, 2008. p. 43-66. ISBN 978-0-470-07474-9.

CANCER; TOLL-LIKE RECEPTORES; RECEPTORES TOLL-SIMILE (TLRS); VACINA; TLR9; CPG ODN

Primeira | Anterior | Próxima | Última